Prognostic Association of Circulating Neutrophil Count with No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction following Successful Primary Percutaneous Intervention
Table 3
Clinical characteristics of patients with normal reflow and no-reflow.
Parameters
Normal reflow ()
No-reflow ()
value
Age (years, ± S)
54.96 ± 11.80
56.11 ± 11.66
0.470
Gender, male, n (%)
269 (88.2)
50 (89.3)
0.815
Smoker, n (%)
212 (69.5)
37 (66.1)
0.609
Hypertension, n (%)
165 (54.1)
30 (53.6)
0.942
Diabetes, n (%)
80 (26.2)
14 (25.0)
0.847
History of PCI, n (%)
18 (5.9)
1 (1.8)
0.330
SBP (mmHg, ± S)
118.8 ± 17.6
116.9 ± 17.7
0.504
DBP (mmHg, ± S)
74.4 ± 11.3
74.6 ± 10.6
0.983
Killip classification, n (%)
0.011
1
82 (26.9)
7 (12.5)
2
206 (67.5)
41 (73.2)
3
12 (3.9)
7 (12.5)
4
5 (1.6)
1 (1.8)
WBC counts (×109/L)
10.99 ± 3.23
11.97 ± 3.61
0.042
Proportion of neutrophils (%)
78.73 ± 11.11
82.73 ± 9.15
0.002
Neutrophil counts (×109/L)
8.79 ± 3.21
10.01 ± 3.45
0.013
Lymphocyte counts (×109/L)
1.61 ± 0.89
1.34 ± 0.45
0.034
Proportion of lymphocytes (%)
15.59 ± 8.69
12.29 ± 7.19
0.002
Neutrophil/lymphocyte ratio
7.17 ± 4.93
9.10 ± 5.19
0.001
Red blood cell counts (×1012/L)
4.66 ± 0.53
4.62 ± 0.56
0.649
HGB (g/L)
143.71 ± 14.55
141.88 ± 15.54
0.391
Platelet counts (×109/L)
212.57 ± 64.85
205.19 ± 57.79
0.467
PDW (%)
12.27 ± 1.87
12.44 ± 1.70
0.529
cTNI (ng/L)
74.09 ± 62.49
94.15 ± 75.05
0.078
Scr (μmol/L)
77.66 ± 21.19
80.45 ± 19.61
0.155
TG (mmol/L)
1.88 ± 1.37
1.70 ± 0.83
0.795
TCHO (mmol/L)
4.65 ± 0.92
4.53 ± 1.00
0.382
HDL-C (mmol/L)
1.00 ± 0.23
1.04 ± 0.25
0.310
LDL-C (mmol/L)
2.97 ± 0.81
2.92 ± 0.90
0.696
GLU (mmol/L)
8.17 ± 2.94
7.95 ± 2.19
0.717
Hs-CRP (mg/L)
10.62 ± 10.48
10.21 ± 9.49
0.869
FBG (g/L)
2.73 ± 0.64
2.64 ± 0.63
0.574
LVDD (mm)
49.70 ± 4.65
49.09 ± 7.81
0.728
EF (%)
54.30 ± 9.49
52.91 ± 10.28
0.355
;. LVDD: left ventricular diastolic diameter; EF: ejection fraction.
